Product

14D high-dose dual therapy

1 clinical trial

1 indication

Indication

Helicobacter pylori infection

Clinical trial

Efficacies of Hybrid, High-dose Dual and Bismuth Quadruple Therapies for the First-line Anti-H Pylori Treatment and Tetracycline-levofloxacin Quadruple Therapy for the Second-line Anti-H Pylori Treatment - a Multicentre Randomized Trial

Status: Completed, Estimated PCD: 2021-12-31